Print page

Akorn Enters into an Exclusive Contract Manufacturing Supply Agreement

PharmaManufacturing.com
09/11/2008

Akorn, Inc. a specialty pharmaceutical company on Sept. 11 announced that it has entered into a ten year exclusive contract manufacturing supply agreement with an undisclosed ophthalmic company.

Under the terms of the ten year agreement, Akorn will be responsible for the development, manufacturing and supply of two new ophthalmic products. Akorn estimates annual manufacturing revenue from this agreement of approximately $2.0 – 3.0 million. These two ophthalmic products are targeted for launch in mid-2009.

Arthur S. Przybyl, Akorn’s President and Chief Executive Officer stated, “This agreement reflects Akorn’s commitment to expanding our contract pharmaceutical manufacturing business unit.”

About Akorn, Inc.

Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey and markets and distributes an extensive line of hospital and ophthalmic pharmaceuticals. Additional information is available at the Company’s website at www.akorn.com.